RIL
SMTI icon

Rothschild Investment LLC’s Sanara MedTech SMTI Stock Holding History

Rothschild Investment LLC’s Portfolio SMTI Stock Details SMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$155 Buy
+9
New +$185 ﹤0.01% 3343

Other funds holding SMTI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SWM
Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Rothschild Investment LLC's SMTI Position: Q1 2026 in Review

Rothschild Investment LLC opened a new position in Sanara MedTech (SMTI) in Q1 2026: 9 shares worth $155. The stake represents ﹤0.01% of the portfolio and ranks #3343 among its holdings.

65 funds tracked by Wall St. Rank hold SMTI as of Q1 2026.

  • Rothschild Investment LLC held 9 shares of Sanara MedTech worth $155 as of Q1 2026.
  • Sanara MedTech was a new Rothschild Investment LLC position in Q1 2026.
  • Sanara MedTech made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q1 2026, its #3343 holding.
  • 65 funds tracked by Wall St. Rank held Sanara MedTech as of Q1 2026.

Based on Rothschild Investment LLC's 13F filing for Q1 2026, filed 7 May 2026.